da Calogero Calcullo | Giu 23, 2016 | Novità dalla letteratura, Rubriche
In 2013, the European Heart Rhythm Association (EHRA) published a Practical Guide on the use of non-VKA oral anticoagulants (NOACs) in patients with atrial fibrillation (AF) (Heidbuchel H, Verhamme P, Alings M, Antz M, Hacke W, Oldgren J, Sinnaeve P, Camm AJ, Kirchhof...
da Calogero Calcullo | Giu 23, 2016 | Novità dalla letteratura, Rubriche
Background Patients with diabetes appear to be at elevated risk of atherothrombotic events. Objectives The purpose of this study was to determine the effect of antiplatelet therapy with ticagrelor on recurrent ischemic events in patients with diabetes and prior...
da Calogero Calcullo | Giu 23, 2016 | Novità dalla letteratura, Rubriche
Direct oral anticoagulants (DOACs) have been used in clinical practice in the United States for the last 4 to 6 years. Although DOACs may be an attractive alternative to warfarin in many patients, long-term outcomes of use of these medications are unknown. We...
da Calogero Calcullo | Apr 10, 2016 | Novità dalla letteratura, Rubriche
Abstract Background Risk stratification in asymptomatic patients remains by far the most important yet unresolved clinical problem in the Brugada syndrome (BrS). Objectives This study sought to analyze the usefulness of electrocardiographic parameters as markers of...
da Calogero Calcullo | Apr 10, 2016 | Linee guida, Novità dalla letteratura, Rubriche
A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines Abstract Background: The optimal duration of dual antiplatelet therapy (DAPT) after implantation of newer- generation drug-eluting stents (DES) remains...
